Correlation Analysis
Incyte Genomics Inc vs VISA Inc.
INCY vs V
+0.208
Light positive
When one moves up, the other tends to follow.
Incyte Genomics Inc
↗INCY
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
Market cap 18.9B · 2,844 employees
VISA Inc.
↗V
Visa is the largest payment processor in the world. In fiscal 2025, it processed almost $17 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.
Market cap 583.4B
Time Series
Relative Performance
Who Moves First
V leads INCY by 6 days
V tends to move before INCY.
After testing 13 timing shifts, the strongest relationship was +0.217 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.040
11 periods · Return correlation when both series rose
Both Falling
-0.083
10 periods · Return correlation when both series fell
Diverging
-0.725
14 periods · Return correlation when series moved apart
R-Squared
4.3%
Share of variance in one series explained by the other.
Trend Agreement
58.0%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,254
Deep shared window — 1,254 usable pairs.
Significance
p < 0.001
95% CI: [0.154, 0.260]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,254 paired data points survived the daily window.
Raw input
1,254
1,254
Normalized
1,254
1,254
Prepared
1,254
1,254
Aligned
1,254
1,254
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
0
A: 0 / B: 0
Series A
Incyte Genomics Inc
INCY
Market cap 18.9B · 2,844 employees
Stock · 1,254 raw → 1,254 prepared
Series B
VISA Inc.
V
Market cap 583.4B
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
3
Estimated crossover points between normalized spreads.
Slope
0.8858
Linear regression slope.
Intercept
198.8781
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 7 hours ago · ID: stock-incy-vs-stock-v-daily